SINGAPORE CAMBO BIOLOGICAL TECHNOLOGY PTE. LTD.

Business Description

SINGAPORE CAMBO BIOLOGICAL TECHNOLOGY PTE. LTD. is registered as a business entity on 09 December 2015 (8.8 years ago) structured as a Private Company Limited By Shares (Local Company) with 2 officer(s) in-charge. The business jurisdiction is overseen by the Accounting and Corporate Regulatory Authority (ACRA), a government agency from Singapore with the given Business Registration Number / Unique Entity Number (UEN) 201542826N. The business official address is located at 152 Beach Road #11-05, Gateway East, Singapore 189721 in the primary industry of 72106: Research And Experimental Development On Medical Science using Singapore Dollars - SGD as its default trading currency. The business legal name has undergone change(s) and is previously known as SINGAPORE KANG BAO BIOLOGICAL TECHNOLOGY PTE. LTD.. The business annual account filing date falls on 31 October and is no longer operational with the status of 'Struck Off'. The business paid up share capital is SGD 1,000,000, with preference share capital of SGD 0, and other share capital at SGD 0.

In the past 365 days, SINGAPORE CAMBO BIOLOGICAL TECHNOLOGY PTE. LTD. has received a total of Login to view reported payment review(s). 0 were rated Good and Login to view were rated Poor. Therefore no payment reviews were made recently. The aggregated good payment amount is equivalent to USD 0, and aggregated poor payment amount is equivalent to USD Login to view. Its current payment rating of "D" suggest a bad payment culture where settlement with stakeholders is frequently past due. Since the business is no longer active, please take caution if you continue transacting as a counter-party. The lack of an appointed auditor indicates that the business is small sized as it did not meet the regulatory requirements of revenue or assets exceeding SGD 10 million, or has more than 50 employees in the previous two fiscal years.

SINGAPORE CAMBO BIOLOGICAL TECHNOLOGY PTE. LTD. is not yet a Prompt Payment Initiative Signatory.

Last updated on 30 April 2023